Company record
Boston Medical Sciences
Updated · Presspool
Virtual bowel-cleansing AI and polyp-detection AI for laxative-free virtual colonoscopy, aiming to end colorectal cancer deaths b-ms.tech
Funding
- ¥5.55 billion Series B, announced November 13, 2026. Led by Japan Growth Capital Investment Corporation, Global Brain and Beyond Next Ventures. Co-led by the three investors; Japan Growth Capital Investment Corporation's assets are managed by Nomura SPARX Investment. Raised through a third-party allotment of new shares. Listed in the AI startup funding roster for November 8–14, 2026. Sources: Boston Medical Sciences announcement, The SaaS News.
Whether AI names Boston Medical Sciences
- Machine Relations Index: Not cited in any Machine Relations Index answer, May 10, 2026 to November 17, 2026.
Related records
Closest rounds in the roster for November 8–14, 2026: SPARETECH ($20 million Series B, November 10, 2026), Zus Health ($33 million Series B, November 10, 2026), LangChain ($300 million Series C, November 13, 2026), Morsa ($1.5 million pre-seed, November 13, 2026), Agentcard ($8 million Seed, November 12, 2026), Agile Robots ($500 million Series F, November 12, 2026).